All lobbying filings

THE NICKLES GROUP, LLC

Lobbying for JAZZ PHARMACEUTICALS, INC. · Pharmaceutical company.

Filing · LD-1 registration Registration

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Dec 1, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 3

BRETT BAKER New on this filing

Previously held: U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff
GREG D'ANGELO New on this filing

Previously held: White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member
MARY BETH SAVARY TAYLOR New on this filing

Previously held: Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Health Issues

Issues related to prescription drugs. Most Favored Nation drug pricing. Regulation of cannabinoids.

Medicare/Medicaid

Issues related to prescription drugs. Most Favored Nation drug pricing. Regulation of cannabinoids.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

JAZZ PHARMACEUTICALS, PLC

Ireland · Dublin · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.